Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells

Por Nieminen, J K, Sipponen, T, Färkkilä, M, Vaarala, O
Publicado em 2014

Increased peripheral blood CD4(+) T cell responses to deamidated but not to native gliadin in children with coeliac disease

Por Lammi, A, Arikoski, P, Vaarala, O, Kinnunen, T, Ilonen, J
Publicado em 2012

Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis

Por Nissinen, R, Leirisalo-Repo, M, Peltomaa, R, Palosuo, T, Vaarala, O
Publicado em 2004

Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes

Por Tiittanen, M, Westerholm-Ormio, M, Verkasalo, M, Savilahti, E, Vaarala, O
Publicado em 2008

Clinical significance of antibodies against oxidised low density lipoprotein in early RA.

Por Paimela, L, Helve, T, Leirisalo-Repo, M, Vaarala, O, Alfthan, G, Palosuo, T, Aho, K
Publicado em 1996

Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-α and interleukin-12 in asymptomatic individuals in response to live spirochetes

Por Sjöwall, J, Carlsson, A, Vaarala, O, Bergström, S, Ernerudh, J, Forsberg, P, Ekerfelt, C
Publicado em 2005

Immune activation in the small intestine in patients with rheumatoid arthritis

Por Nissinen, R, Leirisalo-Repo, M, Nieminen, A, Halme, L, Farkkila, M, Palosuo, T, Vaarala, O
Publicado em 2004

Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein

Por VAARALA, O, PUURUNEN, M, LUKKA, M, ALFTHAN, G, LEIRISALO-REPO, M, AHO, K, PALOSUO, T
Publicado em 1996

Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life

Por BLOMQVIST, M, JUHELA, S, ERKKILÄ, S, KORHONEN, S, SIMELL, T, KUPILA, A, VAARALA, O, SIMELL, O, KNIP, M, ILONEN, J
Publicado em 2002

The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children

Por Jonson, C-O, Hedman, M, Karlsson Faresjö, M, Casas, R, Ilonen, J, Ludvigsson, J, Vaarala, O
Publicado em 2006

Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis

Por Arvonen, M, Vähäsalo, P, Turunen, S, Salo, H M, Mäki, M, Laurila, K, Vaarala, O, Karttunen, T J
Publicado em 2012

Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED)

Por Klemetti, P, Björses, P, Tuomi, T, Perheentupa, J, Partanen, J, Rautonen, N, Hinkkanen, A, Ilonen, J, Vaarala, O
Publicado em 2000

Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD

Por Kurian N, Cohen TS, Öberg L, De Zan E, Skogberg G, Vollmer S, Baturcam E, Svanberg P, Bonn B, Smith PD, Vaarala O, Cunoosamy DM
Publicado em 2019-11-01

Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes

Por Lahdenperä, A I, Hölttä, V, Ruohtula, T, Salo, H M, Orivuori, L, Westerholm-Ormio, M, Savilahti, E, Fälth-Magnusson, K, Högberg, L, Ludvigsson, J, Vaarala, O
Publicado em 2012